Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism

American Journal of Hypertension

Volumn 18, Issue 3, 2005, Pages 354-357

  Kato, Johji ^a   Etoh, Takuma ^a   Kitamura, Kazuo ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Blood volume; Cardiac load; Natriuretic peptides; Primary aldosteronism

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HUMAN ALBUMIN; IODINE 131;

ADRENAL CORTEX ADENOMA; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE MARKER; FEMALE; HEART VOLUME; HEART WORK; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; MALE; MEAN ARTERIAL PRESSURE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

EID: 15744399837     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.09.016     Document Type: Article

References (14)

1. E.R. Levin, D.G. Gardner, W.K. Samson Natriuretic peptides N Engl J Med 339 1998 321 328
2. A.J. de Bold, K.K. Ma, Y. Zhang, M.L.K. de Bold, M. Bensimon, A. Khoshbaten The physiological and pathophysiological modulation of the endocrine function of the heart Can J Physiol Pharmacol 79 2001 705 714
3. J. Kato, T. Eto Natriuretic peptides L. Martini Encyclopedia of Endocrine Diseases 2004 Academic Press San Diego 287 290
4. J. Kato, K. Kobayashi, T. Etoh, M. Tanaka, K. Kitamura, T. Imamura, Y. Koiwaya, K. Kangawa, T. Eto Plasma adrenomedullin concentration in patients with heart failure J Clin Endocrinol Metab 81 1996 180 183
5. T.J. Tunny, R.D. Gordon Plasma atrial natriuretic peptide in primary aldosteronism (before and after treatment) and in Bartter's and Gordon's syndromes Lancet 1 1986 272 273
6. M. Naruse, Y. Takeyama, A. Tanabe, J. Hiroshige, K. Naruse, T. Yoshimoto, M. Tanaka, T. Katagiri, H. Demura Atrial and brain natriuretic peptides in cardiovascular diseases Hypertension 23 1994 I-231 I-234 (Suppl)
7. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, M. Jougasaki, H. Ogawa, K. Okumura, M. Mukoyama, K. Nakao Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
8. J. Kato, K. Kitamura, E. Matsui, M. Tanaka, Y. Ishizaka, T. Kita, K. Kangawa, T. Eto Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension Hypertens Res 22 1999 61 65
9. R.C. Tarazi, E.D. Frohlich, H.P. Dustan Plasma volume in men with essential hypertension N Engl J Med 278 1968 762 765
10. P. Weidmann, D. Hirsch, C. Beretta-Piccoli, F.C. Reubi, W.H. Ziegler Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension Am J Med 62 1977 209 218
11. N.M. Kaplan Primary aldosteronism N.M. Kaplan Kaplan's Clinical Hypertension 2002 Lippincott Williams & Wilkins Philadelphia 455 479
12. H. Muratani, T. Kawasaki, T. Omae A possible role of hypokalemia in the manifestation of high QRS voltage and sinus bradycardia in patients with primary aldosteronism Jpn Circ J 48 1984 994 999
13. M. Maciejewska, B. Dabrowska Influence of serum potassium on the electrocardiographic pattern of left ventricular hypertrophy in primary hyperaldosteronism Clin Cardiol 15 1992 725 727
14. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, T. Omland, P.A. Wolf, R.S. Vasan Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663